Effectiveness of Influenza Antiviral Treatment in Outpatient Settings
NOV 02, 2016 | CONTAGION EDITORIAL STAFF
Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, explains how antiviral flu treatments may be affecting patients in the outpatient setting.
Interview Transcript (slightly modified for readability)
“[Data on] the effectiveness of influenza antiviral treatment in the outpatient setting is somewhat limited; but what data we do have from a large trial that looked at ten clinical trials shows that patients who are given antiviral treatment as opposed to those who aren’t and who have influenza, are 50% less-likely to have a secondary complication such as pneumonia.
There [are] also studies that show that children who are given Tamiflu early have lower rates of complications such as otitis media, or ear infections. In the hospitalized setting we see a lower rate of severe clinical outcomes, including death, among people who are receiving antiviral treatment.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512